Search the Newsreel

BioCryst Pharmaceuticals, Inc. Revenue Breakdown – NASDAQ:BCRX

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) generated $874.84 million in revenue last year, primarily from its Oral Small-molecule and Injectable Protein Therapeutics segment. This represents a significant increase from $450.71 million in the previous year. The United States was the largest contributor to revenue, accounting …

AudioCodes Ltd expected to post earnings of 14 cents a share - Earnings Preview

AudioCodes Ltd (AUDC) is expected to announce earnings of 14 cents per share. This article serves as an earnings preview for the company.

Riocan Real Estate Investment Trust's Dividend Analysis

This article first appeared on GuruFocus. Assessing the Sustainability and Future of RIOCF's Monthly Payouts Riocan Real Estate Investment Trust (RIOCF) recently announced a total dividend of $0.07 per share, with the ex-dividend date set for 2026-07-31. This payment includes $0.07 per share in …

AUDC|AudioCodes Ltd|Price:9.580|Chg%:+0.330

This article provides a comprehensive stock analysis of AudioCodes Ltd (AUDC) by TradingKey. It highlights the company's relatively healthy fundamentals, high growth potential, and fair valuation, ranking 28th in its industry. The analysis also notes strong institutional ownership, a "Buy" rating from analysts with …

BioCryst Pharmaceuticals Inc (BCRX) Institutional Confidence

BioCryst Pharmaceuticals Inc (BCRX) has a high institutional shareholding score of 10.00, ranking 1st in its industry, despite a recent 10.51% quarter-over-quarter decrease in institutional shareholding proportion. The largest institutional shareholder is James Simons, and notable institutional holders include BlackRock, RA Capital Management, and …

Q1 Results: Maruti Suzuki, Sun Pharma, ITC, Bajaj Finserv, Indian Oil, ABB India, GAIL, Urban Company, Dixon Tech, others to post earnings on July 31

BioCardia (BCDA) Q1 2026 Earnings: Wider EPS Loss of $0.21 Misses Estimates, Yet Stock Climbs 5.04%

AudioCodes (Nasdaq:AUDC) - Stock Analysis

AudioCodes (Nasdaq:AUDC) provides advanced communication software and productivity solutions for the digital workplace. The company's stock has shown mixed performance, with analysts maintaining a fair value estimate of $12.50 despite recent earnings misses and profit margin declines. AudioCodes is actively repurchasing shares and expanding …

BioCardia CEO Peter Altman buys $3,900 in common stock

BioCardia CEO Peter Altman purchased 5,000 shares of the company's common stock for $3,900 on July 29, 2026, at a weighted average price of $0.78 per share. This transaction occurred while the stock was trading near its 52-week low, and InvestingPro analysis suggests it …

Bioceres Crop Solutions Corp (BIOX) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Bioceres Crop Solutions Corp (BIOX), highlighting its current valuation score and P/E ratio. The company's valuation score is 7.21, ranking it 45th in the Chemicals industry. It notes that key P/E, P/B, P/S, and P/CF data have …

Earnings Preview: AudioCodes to Report Financial Results Pre-market on August 04

AudioCodes (AUDC) is scheduled to release its second-quarter 2026 financial results pre-market on August 4. The company's EPS is expected to decline by 14.3% year-over-year to $0.24, while revenue is projected to grow by 10.1% to $67.4 million. Investors will be keen to see …

Form 4 Biocardia Inc For: 29 July By Investing.com

This article reports on a Form 4 filing for Biocardia Inc (BCDA) related to activities on July 29, consistent with insider trading disclosures. The article is a brief announcement from Investing.com, typical of filings news. No specific details of the Form 4 are provided …

BioCardia (NASDAQ: BCDA) CEO buys 5,000 shares at $0.78

BioCardia, Inc. (NASDAQ: BCDA) President and CEO Peter Altman purchased 5,000 shares of common stock on July 29, 2026, at a weighted average price of $0.78 per share. The transaction, executed in multiple trades between $0.77 and $0.80, increases his direct holdings to 373,885 …

BlackRock (NB holder) discloses 9.0M-share, 6.2% position in NIOCORP

BlackRock, Inc. has filed a Schedule 13G disclosing a 6.2% beneficial ownership stake in NIOCORP DEVELOPMENTS LTD, totaling 9,013,741 common shares. The filing indicates BlackRock holds sole voting power over 8,796,392 shares and sole dispositive power over all 9,013,741 shares. No single underlying client …

Price to earnings forward of NioCorp Developments Ltd. – NASDAQ:NIOBW

This article provides financial data specifically on the "Price to earnings forward" for NioCorp Developments Ltd. (NASDAQ:NIOBW). It appears to be a stub or a data point from a financial platform like TradingView, indicating no available value or recent trades for this metric. The …

AudioCodes Ltd (AUDC) Institutional Confidence

AudioCodes Ltd (AUDC) has an institutional shareholding score of 3.00, placing it 36th out of 54 in the Communications & Networking industry. The latest institutional shareholding proportion is 40.15%, a 14.26% decrease quarter-over-quarter. Bill Nygren | OAKMX is the largest institutional shareholder with 227.18K …

Bioceres Crop Solutions Corp (BIOX) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Bioceres Crop Solutions Corp (BIOX), ranking it 59 out of 65 in the Chemicals industry with a score of 1.99. It details the company's beta of 0.38, indicating underperformance in rising markets but smaller declines in falling …

BioCryst Pharmaceuticals (BCRX) Expected to Announce Quarterly Earnings on Wednesday

AudioCodes Ltd (AUDC) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for AudioCodes Ltd (AUDC), highlighting its current valuation score, P/E ratio, and industry ranking. The company's valuation score is 8.23, placing it 27th out of 54 in the Communications & Networking industry. It notes that other key valuation …

AudioCodes Ltd (AUDC) Financial Health: Profitability & Balance Sheet Analysis

AudioCodes Ltd (AUDC) has a stable financial status with high operating efficiency, ranking 11th out of 54 in the Communications & Networking industry with a financial score of 8.18. The company reported a quarterly revenue of $62.14 million, marking a 2.93% year-over-year increase, and …

BCRX|BioCryst Pharmaceuticals Inc|Price:9.609|Chg%:-0.131

This article provides a comprehensive stock analysis of BioCryst Pharmaceuticals Inc (BCRX), highlighting its relatively healthy fundamentals, high growth potential, and "fairly valued" status within the Biotechnology & Medical Research industry. It notes strong institutional ownership, a consensus "Buy" rating from analysts with a …

(AUDC) Movement Within Algorithmic Entry Frameworks

Audiocodes Ltd. (NASDAQ: AUDC) is currently exhibiting a neutral sentiment across all horizons, suggesting a wait-and-see approach. The article highlights an exceptional 37.7:1 risk-reward short setup and provides institutional trading strategies for different risk profiles, including position trading, momentum breakout, and risk hedging. Multi-timeframe …

NioCorp Developments Market Sentiment

This article provides an overview of NioCorp Developments (NB) market sentiment, including analyst consensus, short interest, options flow, and insider activity. Key signals indicate a "Buy" consensus from analysts, 6.8% short interest, and a bullish options flow with a 0.38 Put/Call ratio. The piece …

NioCorp Developments Ltd. Revenue Breakdown – GETTEX:BR30

This article provides a brief overview of NioCorp Developments Ltd.'s financial information available on TradingView, specifically focusing on its revenue breakdown. It highlights the availability of financial statements, statistics, dividends, earnings, and segment performance data for the company's stock under the GETTEX:BR30 ticker. The …

AudioCodes (AUDC) Expected to Announce Earnings on Tuesday

AudioCodes (AUDC) is scheduled to release its Q2 2026 earnings before market open on Tuesday, August 4th. Analysts anticipate earnings of $0.14 per share on revenue of $62.42 million. The company's stock was recently up 2.1% to $9.78, and institutional investors hold a significant …

Bioceres Crop Solutions Corp (BIOX) Institutional Confidence

The institutional confidence score for Bioceres Crop Solutions Corp (BIOX) is 3.00, placing it 50th out of 65 in the Chemicals industry. Institutional shareholding declined by 15.96% quarter-over-quarter to 31.92%. Bill Nygren | OAKMX is the largest institutional shareholder, holding 0.01% of outstanding shares.

BCDA|BioCardia Inc|Price:0.795|Chg%:-0.013

This article provides a comprehensive stock analysis of BioCardia Inc (BCDA) from TradingKey, highlighting its strong fundamentals and high growth potential despite recent weak stock market performance. The company is developing cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases, with product candidates in …

AUDC Q2'26 Earnings: revenue estimate is 62.42M USD

BioCardia Inc (BCDA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

The article provides a revenue breakdown for BioCardia Inc (BCDA), focusing on business segments and regional contributions. However, it indicates that relevant data for these categories have not yet been disclosed by the company. The page also displays current stock information and market cap …

AudioCodes Ltd. Revenue Breakdown – FWB:AU1

AudioCodes Ltd. (FWB:AU1) generated 209.11 million EUR in revenue last year. Its Services segment was the top performer, bringing in 111.27 million EUR, a decrease from 125.78 million EUR in the prior year. The United States was the largest regional contributor, accounting for 108.74 …

BioCardia Inc (BCDA) Cash Flow

The article provides a detailed cash flow statement for BioCardia Inc (BCDA), including operating, investing, and financing cash flows, with data presented quarterly and annually. It highlights key financial figures such as BioCardia Inc's operating cash flow of -7.44M in fiscal year 2025 and …

BioCryst Pharmaceuticals Inc (BCRX) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of BioCryst Pharmaceuticals Inc (BCRX), noting its current valuation score of 8.70, ranking 95th in its industry. It highlights the company's P/E ratio of -5.56 and states that relevant data for P/B, P/S, and P/CF ratios have not …

AudioCodes Ltd (AUDC) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of AudioCodes Ltd (AUDC), focusing on its price momentum, support and resistance levels, and various technical indicators and moving averages. AUDC has a current price momentum score of 2.83, ranking low in its industry, and is trading between …

The West's Rare Earth Comeback Has Finally Begun

This article reports on the West's effort to regain control over rare earth production, highlighting China's desperate attempts to exclusively control manufacturing within its borders through new export restrictions. These restrictions specifically target American plans to begin commercial production of rare earth magnet materials …

AudioCodes Ltd (AUDC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for AudioCodes Ltd (AUDC), categorizing its income by business segments and geographical regions. As of April 6, 202X, Networking contributed 53.21% of revenue, and Technology 46.79%. Regionally, the United States accounted for 52.11% of revenue, followed by …

Bioceres Crop Solutions Corp (BIOX) Income Statement

This article provides the quarterly and annual income statements for Bioceres Crop Solutions Corp (BIOX), offering detailed financial data such as total revenue, operating expenses, net income, and earnings per share. It also includes an FAQ section explaining how to interpret income statements and …